Clinical Trial Update: Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating metformin in combination with a levonorgestrel-releasing intrauterine system for Complex atypical hyperplasia of the endometrium and En…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complex Atypical Hyperplasia of the Endometrium
• Endometrial Cancer

Drugs mentioned

• Levonorgestrel-Releasing Intrauterine System (levonorgestrel-releasing intrauterine system)
• metformin (metformin)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Complex Atypical Hyperplasia, Endometrial Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-12-18